Publication & Citation Trends
Publications
0 total
FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages.
Cited by 0
Semantic Scholar
Abstract 7951: Ovarian tumor FAK inhibition releases omega-3 fatty acids stimulating GATA6 peritoneal macrophage CXCL13 production augmenting TIGIT immunotherapy
Cited by 0
Semantic Scholar
Abstract 6491: Co-treatment with FAK and PARP inhibitors for the treatment of homologous recombination-proficient high grade serious ovarian cancer
Cited by 0
Semantic Scholar
Abstract A022: FAK and PARP coinhibition in maintenance therapy for homologous recombination-proficient (HRP) high grade serous ovarian cancer
Cited by 0
Semantic Scholar
Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor Microenvironment
Cited by 1
Semantic Scholar
Inducible FAK Loss but not FAK Inhibition in Endothelial Cells of PYK2-null Mice Activates p53 Tumor Suppressor to Prevent Tumor Growth.
Cited by 4
Semantic Scholar
A non-apoptotic caspase-8–meteorin pathway in hepatocytes promotes MASH fibrosis
Cited by 3
Semantic Scholar
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing Immunotherapy
Cited by 0
Semantic Scholar
Research Topics
Autophagy in Disease and Therapy
(7)
Microfluidic and Capillary Electrophoresis Applications
(2)
Cancer-related Molecular Pathways
(2)
RNA Interference and Gene Delivery
(2)
Cell Adhesion Molecules Research
(2)
Affiliations
Scripps Research Institute
University of Macau
UC San Diego Health System
University of California San Diego
Institute for Molecular Medicine Finland